pexels sharon mccutcheon 1566909

Future-proofing old school pharma with new biology

It is seems just about every week one of the major news and analysis publications such as The Economist, The New York Times, FORBES, TIME or some other major ublication drills into the hotbutton issue of the perceived disparity between oncology drug pricing and medical-economic value. It is a situation that is undeniably acute considering the following; … published with kind permission of Drug Discovery World (